載入...
Spasticity and Its Contribution to Hypertonia in Cerebral Palsy
Spasticity is considered an important neural contributor to muscle hypertonia in children with cerebral palsy (CP). It is most often treated with antispasticity medication, such as Botulinum Toxin-A. However, treatment response is highly variable. Part of this variability may be due to the inability...
Na minha lista:
| 發表在: | Biomed Res Int |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi Publishing Corporation
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4306250/ https://ncbi.nlm.nih.gov/pubmed/25649546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/317047 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|